Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Quotazioni in diretta
| Data | Ora | Fonte | Titolo |
|---|---|---|---|
| 18/6/2024 | 22:09 | EDGAR2 | Form 8-K - Current report |
| 18/6/2024 | 22:01 | BW | Akili Announces FDA Authorization of EndeavorOTC, the First.. |
| 03/6/2024 | 23:21 | EDGAR2 | Form SC TO-T - Tender offer statement by Third Party |
| 29/5/2024 | 23:32 | EDGAR2 | Form SC TO-C - Written communication relating to an issuer.. |
| 29/5/2024 | 22:05 | EDGAR2 | Form SC14D9C - Written communication relating to third party.. |
| 29/5/2024 | 15:16 | EDGAR2 | Form SC14D9C - Written communication relating to third party.. |
| 29/5/2024 | 15:14 | EDGAR2 | Form 8-K - Current report |
| 29/5/2024 | 14:00 | BW | Virtual Therapeutics, Akili Interactive Enter Into.. |
| 14/5/2024 | 22:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 14/5/2024 | 22:10 | EDGAR2 | Form 8-K - Current report |
| 14/5/2024 | 22:01 | BW | Akili Reports First Quarter 2024 Financial Results and.. |
| 06/5/2024 | 23:32 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 30/4/2024 | 14:00 | BW | Akili Announces Amended Agreement with Shionogi, Shift in.. |
| Apertura: | Min: | Max: |
| Chiusura: 0,432 |
|
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni |
|
ADVFN Network
|
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
